The availability of drugs for stable COPD treatment in China: a cross-sectional survey
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
This survey aimed to investigate the availability of drugs for stable chronic obstructive pulmonary disease (COPD) treatment in Chinese hospitals and to determine whether drug availability significantly varied among hospitals with different characteristics. A well-constructed questionnaire was designed according to the Chinese Guidelines for the Diagnosis and Management of COPD (revised version 2021). Both inhaled drugs (monotherapy, double therapy and triple therapy) and oral drugs (expectorants, theophylline, antibiotics, and bacterial lysates) were included in this survey. Doctors from different hospitals completed the survey via WeChat. The availability of each category and kind of drug was analyzed based on final valid responses. Subgroup analyses were also conducted to reveal drug availability in hospitals with different characteristics. A total of 1018 hospitals with different characteristics were enrolled in this survey, with 53.73% of which establishing independent respiratory departments. Insufficient supply of COPD-related drugs was observed, with only short-acting β2 agonists (80.6%), expectorants (88.2%) and antibiotics (84.3%) reaching 80%. Results of subgroup analyses suggested that primary hospitals were associated with poorer availability of all kinds of drugs than secondary and tertiary hospitals (all p < 0.001). Most inhaled drugs did not reach an availability of 20% in primary hospitals, except for salbutamol (59.7%), tiotropium bromide (20.0%) and beclometasone/formoterol (23.1%). Results of this survey suggested that the availability of drugs for COPD treatment in China is still an ongoing challenge for healthcare institutions. Insufficient drug supply and imbalanced drug availability among different hospitals are major barriers that warrant further improvements.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- The availability of drugs for stable COPD treatment in China: a cross-sectional survey
- Date Crossref
- 25/01/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Sichuan University Department of Pulmonary and Critical Care Medicine pays non établi dans la noticeUniversité ou école supérieure
-
West China Hospital of Sichuan University pays non établi dans la noticeÉtablissement de santé
-
University of Electronic Science and Technology of China Department of Geriatrics pays non établi dans la noticeUniversité ou école supérieure
-
Suizhou Central Hospital pays non établi dans la noticeÉtablissement de santé
-
Hunan University Department of Pulmonary and Critical Care Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Mianyang Central Hospital Department of Pulmonary and Critical Care Medicine pays non établi dans la noticeÉtablissement de santé
-
Tibet University pays non établi dans la noticeUniversité ou école supérieure
-
Army Medical University pays non établi dans la noticeUniversité ou école supérieure
-
Daping Hospital Department of Pulmonary and Critical Care Medicine pays non établi dans la noticeÉtablissement de santé
-
Zunyi Medical University Department of Respiratory and Critical Care Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Suining Central Hospital Department of Pulmonary and Critical Care Medicine pays non établi dans la noticeÉtablissement de santé
-
The People's Hospital of Leshan Department of Pulmonary and Critical Care Medicine pays non établi dans la noticeÉtablissement de santé
Department of Pulmonary and Critical Care Medicine — Sichuan University, West China Hospital of Sichuan University et Department of Geriatrics — University of Electronic Science and Technology of China, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.